Stock screenerAll disclosures →
EDGAR →
CGON
Conviction 76HealthcareScan · Thu, Jun 25, 2026CGON$72.84+6.00%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.24M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price72.84
Change+6.00%
Gap-2.71%
Rel volume3.44×
Avg volume1.15M
Avg $ vol70.88M
SMA 2060.00
SMA 5064.49
SMA 20052.61
Price vs 50+12.95%
Price vs 200+38.45%
MA stackbullish
50/200 cross—
Supertrendup · 58.21
RSI (14)71
MACD hist1.89
MACD crossbull · 8d
Stoch %K / %D97 / 92
ADX (14)25
+DI / −DI32 / 11
RSI divergence—
MACD divergence—
ATR %+4.98%
ADR %5.53%
52w high74.00
52w low23.95
From 52w high-1.57%
Above 52w low+204.20%
New 52w highNo
SqueezeOff
Bollinger width33.35%
%B1.14
Donchian pos96.94%
Donchian high73.46
Donchian low53.21
AVWAP (52w high)62.51
vs AVWAP high+16.52%
AVWAP (52w low)52.16
vs AVWAP low+39.65%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d3.44×
Avg vol (14d)1.24M
Avg vol (20d)1.15M
Avg $ vol (20d)70.88M
Market cap6.42B
RS 3m (vs SPY)-4.61%
RS 6m (vs SPY)+68.33%
RS line new highNo
Trend template7/8
Technical rank92.8
1 week+20.54%
1 month+17.69%
3 months+10.68%
6 months+81.74%
1 year+182.33%
YTD+74.30%
P/E-39.91
P/B5.88
P/S—
P/FCF-48.50
EPS-2.08
Div yield—
ROE-14.75%
ROA-14.18%
Debt/Eq0.00
Current31.30
EV/EBITDA-33.77
Gross margin—
Net margin—
Rev growth254.70%
EPS growth-82.87%
Price target91.55
Target upside25.69%
Analyst ratingBuy
Institutional109.26%
Ent. value6.39B
Revenue1.08M
Net income-60.2M
Gross profit—
Free cash flow-132.48M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out88.2M
Employees142
ListedThu, Jan 25, 2024
Free float55.61M
Float %68.9%
Short interest9.81M
Days to cover10.2d
Short volume62.2%
Squeeze score90 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.71 vs −$0.58
Last surprise-22.4% miss
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank92.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance72.60
Support56.16
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CGON
No recent disclosed trades by Congress in CGON. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CGON · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
POST LEONARD E Director · Common Stock · 2026-06-24 | Exercise | 5K | $3K | 2026-06-24 | 2026-06-25 |
POST LEONARD E Director · Common Stock · 2026-06-24 | Sell | 5K | $350K | 2026-06-24 | 2026-06-25 |
POST LEONARD E Director · Director Stock Option (right to buy) · 2026-06-24 | Exercise | 5K | — | 2026-06-24 | 2026-06-25 |
Mulay James Director · Common Stock · 2026-06-15 | Exercise | 654 | $2K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Common Stock · 2026-06-15 | Sell | 654 | $39K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Common Stock · 2026-06-15 | Exercise | 1.31K | $16K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Common Stock · 2026-06-15 | Sell | 1.31K | $79K | 2026-06-15 | 2026-06-16 |
Mulay James Director · Director Stock Option (right to buy) · 2026-06-15 | Exercise | 654 | — | 2026-06-15 | 2026-06-16 |
Mulay James Director · Director Stock Option (right to buy) · 2026-06-15 | Exercise | 1.31K | — | 2026-06-15 | 2026-06-16 |
POST LEONARD E Director · Common Stock · 2026-06-04 | Sell | 1K | $55K | 2026-06-04 | 2026-06-05 |
SEC filings
EDGAR filings in CGON · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.